据报台积电内部评估加码投资美国晶片厂
《路透社》报道,台积电(TSM.US)正在评估增加在美国亚利桑那州晶片厂房数百亿美元的投资计划,但在欧洲建厂的前景未明。
台积电去年集团宣布斥资100亿至120亿美元在凤凰城设立晶片厂,据悉这将会是最多兴建6间厂房计划的首间工厂,目前集团内部正讨论应否兴建一个更先进能生产3纳米晶片的厂房,但成本可能介乎230亿至250亿美元之间。
另外,欧盟亦拉拢晶片生产商在当地设厂,但据悉欧盟工业专员Thierry Breton上月与台积电欧洲总裁Maria Marced的讨论失败告终。
台积电发言人称,公司没有排除任何发展的可能性,但目前没有在欧洲设厂的计划。消息人士称,台积电不排除为车厂在欧洲建立生产较旧款晶片的工厂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.